搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
on MSN
Why Is Sanofi (SNY) Among the Best European Dividend Stocks To Buy Now?
We recently compiled a list of the 10 Best European Dividend Stocks To Buy. In this article, we are going to take a look at ...
来自MSN
1 天
Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III
Sanofi SNY and its partner SK bioscience announced that they have expanded their agreement to develop, license and ...
6 天
on MSN
Teva, Sanofi say bowel disease drug met primary targets (Dec 17)
Teva and Sanofi said last year they would collaborate on developing a treatment for inflammatory bowel disease (IBD), hoping ...
1 天
Sanofi Appoints Jean-Paul Kress to Board of Directors
Sanofi has announced the appointment of Jean-Paul Kress as an independent director to its Board, effective January 1, 2025. Kress, with over 30 years of experience in the pharmaceutical industry, ...
FierceBiotech
1 天
Sanofi pays SK bioscience €50M as children's pneumococcal vaccine enters phase 3
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal ...
STAT
10 天
Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug ...
The 340B program has become a flash point in the growing debate over the cost of prescription drugs in the U.S.
6 天
Teva, Sanofi say bowel disease drug met primary targets
Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...
2 天
Sanofi To Expand Collaboration With SK Bioscience For Next-generation Pneumococcal Vaccines
Sanofi (SNYNF, SNY) and SK bioscience have entered an expanded agreement to develop, license and commercialize next-generation ...
腾讯网
11 天
穿越血脑屏障,赛诺菲BTK抑制剂获FDA突破性疗法认定
▎药明康德内容团队编辑赛诺菲(Sanofi)公司今日宣布,美国FDA已授予在研布鲁顿氏酪氨酸激酶(BTK)抑制剂tolebrutinib突破性疗法认定,用于治疗患有非复发性继发进展型多发性硬化(nrSPMS)的成年患者。突破性疗法认定旨在加速针对严重或危及生命疾病的药物的开发与审评。获得该认定的药物需显示出初步临床证据,证明其在 ...
7 天
Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug
Teva stock catapulted Tuesday after its inflammatory bowel disease treatment showed "best-in-class potential" in a Phase 2 ...
7 天
Sanofi's 340B Credit Proposal Draws Federal Warning For Statutory Violation
HRSA warns Sanofi that its credit model for 340B drugs violates the statute, demanding immediate cessation to avoid penalties ...
FierceBiotech
7 天
Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in ...
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈